Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

Byung-Hyun Lee, MD, Ka-Won Kang, MD, Min Ji Jeon, MD, Eun Sang Yu, MD, Dae Sik Kim, MD PhD, Hojoon Choi, MD, Se Ryun Lee, MD PhD, Hwa Jung Sung, MD PhD, Yong Park, MD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3099.

https://doi.org/10.1182/blood-2018-99-115694

Published: 2018

Journal Articles

One-Day Low-Dose Etoposide Is an Effective Chemomobilization Regimen with Minimal Toxicity for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Multicenter Study from Tertiary Hospitals in Korea

Yong Park, MD, Dae Sik Kim, MD PhD, Ka-Won Kang, MD, Byung-Hyun Lee, MD, Eun Sang Yu, MD, Min Ji Jeon, MD, Hojoon Choi, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Kihyun Kim, MD PhD, Byung Soo Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3347.

https://doi.org/10.1182/blood-2018-99-115625

Published: 2018

Journal Articles

Immature Platelet Fraction Based Diagnostic Predictive Model for Immune Thrombocytopenic Purpura

Min Ji Jeon, MD, Hojoon Choi, MD, Eun Sang Yu, MD, Ka-Won Kang, MD, Byung-Hyun Lee, MD, Dae Sik Kim, MD PhD, Yong Park, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2018) 132 (Supplement 1): 1149.

https://doi.org/10.1182/blood-2018-99-117754

Published: 2018

Journal Articles

The Potential of Exosomes Derived from Chronic Myelogenous Leukemia Cells As Biomarker Based on the BCR-ABL mRNA Transcript

Ka-Won Kang, MD, Jik-han Jung, Woojune Hur, Jaena Park, Hyunku Shin, ByeongHyeon Choi, Hyesun Jeong, Dae Sik Kim, MD PhD, Eun Sang Yu, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Seok Jin Kim, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD, Hyun Koo Kim, MD PhD, Sunghoi Hong, PhD, Ji-ho Park, PhD, Yeonho Choi, PhD, Yong Park, MD PhD

Blood (2017) 130 (Supplement 1): 2883.

https://doi.org/10.1182/blood.V130.Suppl_1.2883.2883

Published: 2017

Journal Articles

Routine Imaging for Surveillance in Patients with Aggressive Non-Hodgkin Lymphoma in Complete Remission after Frontline Chemotherapy

Ka-Won Kang, MD, Dae Sik Kim, MD PhD, Eun Sang You, MD, Yong Park, MD PhD, Se Ryeon Lee, Hwa Jung Sung, MD PhD, Seok Jin Kim, Chul Won Choi, MD PhD, Byung Soo Kim

Blood (2016) 128 (22): 3041.

https://doi.org/10.1182/blood.V128.22.3041.3041

Published: 2016

Journal Articles

Impact of G-CSF for Outcomes of Non-M3 AML Patients Who Were Treated By Anthracycline-Based Induction (7+3 regimen) Chemotherapies

Ka-Won Kang, MD, Yong Park, MD PhD, Dae Sik Kim, MD PhD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Seok Jin Kim, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2015) 126 (23): 4889.

https://doi.org/10.1182/blood.V126.23.4889.4889

Published: 2015

Journal Articles

High-Dose Cytarabine Alone Versus Cytarabine Plus Anthracycline for Consolidation Therapy in Non-Promyelocytic Acute Myeloid Leukemia

Sung-Hyun Kim, So Yeon Kim, Ji Hyun Lee, MD PhD, Suee Lee, Sung Yong Oh, Hyo-Jin Kim, Dae Sik Kim, MD, Ka-Won Kang, MD, Se Ryeon Lee, MD PhD, Yong Park, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Byung Soo Kim, MD PhD

Blood (2015) 126 (23): 4890.

https://doi.org/10.1182/blood.V126.23.4890.4890

Published: 2015

Journal Articles

Bilateral Optic Nerve Invasion of Extranodal Marginal Zone B Cell Lymphoma with Leukemic Subtype

Hwa Jung Sung, MD, PhD, Eui Bae Kim, MD, Se Ryeon Lee, MD, PhD, Kyong Hwa Park, MD, PhD, In Keun Choi, MD, PhD, Sang Chul Oh, MD, PhD, Byung Soo Kim, MD, PhD, Yeul Hong Kim, MD, PhD, Jun Suk Kim, MD, PhD, Hee Yun Seo, MD, Sun Hyung Kim, MD, Soo-Young Yoon, MD, PhD

Blood (2008) 112 (11): 5285.

https://doi.org/10.1182/blood.V112.11.5285.5285

Published: 2008

Journal Articles

Mitoxantrone, Etoposide, and Intermediate-Dose Cytarabine in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia : Single-Center Experience

Hwa Jung Sung, MD, PhD, Eui Bae Kim, MD, Se Ryeon Lee, MD, PhD, Hee Yun Seo, MD, Kyong Hwa Park, MD, PhD, In keun Choi, MD, PhD, Sang Chul Oh, MD, PhD, Chul Won Choi, MD, PhD, Byung Soo Kim, MD, PhD, Yeul Hong Kim, MD, PhD, Jun Suk Kim, MD, PhD

Blood (2008) 112 (11): 4007.

https://doi.org/10.1182/blood.V112.11.4007.4007

Published: 2008

Journal Articles

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Seok Jin Kim, MD, PhD, Hwa Jung Sung, MD, PhD, Chul Won Choi, MD, PhD, In Sun Kim, MD, PhD, Byung Soo Kim, MD, PhD, Soo-Young Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Jun Suk Kim, MD, PhD

Blood (2007) 110 (11): 1575.

https://doi.org/10.1182/blood.V110.11.1575.1575

Published: 2007

Journal Articles

Detection of Extracellular Protein Kinase A (ECPKA) Autoantibody in Non-Hodgkin’s Lymphoma: Its Increased Antibody Titer Decreases with a Favorable Treatment Response.

Chul Won Choi, MD, Hee Yun Seo, MD, Hwa Jung Sung, MD, Soo-Young Yoon, MD, Seok Jin Kim, MD, Byung Soo Kim, MD, Jun Suk Kim, MD, Meyoung-Kon Kim, MD

Blood (2006) 108 (11): 4621.

https://doi.org/10.1182/blood.V108.11.4621.4621

Published: 2006

Journal Articles

Treatment Outcome of Localized Extranodal NK/T Cell Lymphoma in Nasal and Upper Aerodigestive Tract: A Single Institue Experience in Korea.

Seok Jin Kim, MD, Hwa Jung Sung, MD, In Keun Choi, MD, Byung Soo Kim, MD, Chul Won Choi, MD, Jun Suk Kim, MD, In Sun Kim, MD, Soo-Young Yoon, MD, Chul Yong Kim, MD

Blood (2005) 106 (11): 2682.

https://doi.org/10.1182/blood.V106.11.2682.2682

Published: 2005

Journal Articles

Prediction of Survival in Patients with Non-Hodgkin’s Lymphoma: Role of Tumor Necrosis Factor Ligand-Receptor and Extracellular Protein Kinase A.

Chul Won Choi, MD, Soo-Young Yoon, MD, Hwa Jung Sung, MD, In Keun Choi, MD, Seok Jin Kim, MD, Sang Cheul Oh, MD, Jae Hong Seo, MD, Byung Soo Kim, MD, Sang Won Shin, MD, Yeul Hong Kim, MD, Jun Suk Kim, MD

Blood (2005) 106 (11): 4737.

https://doi.org/10.1182/blood.V106.11.4737.4737

Published: 2005

NARROW

Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

One-Day Low-Dose Etoposide Is an Effective Chemomobilization Regimen with Minimal Toxicity for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Multicenter Study from Tertiary Hospitals in Korea

Immature Platelet Fraction Based Diagnostic Predictive Model for Immune Thrombocytopenic Purpura

The Potential of Exosomes Derived from Chronic Myelogenous Leukemia Cells As Biomarker Based on the BCR-ABL mRNA Transcript

Routine Imaging for Surveillance in Patients with Aggressive Non-Hodgkin Lymphoma in Complete Remission after Frontline Chemotherapy

Impact of G-CSF for Outcomes of Non-M3 AML Patients Who Were Treated By Anthracycline-Based Induction (7+3 regimen) Chemotherapies

High-Dose Cytarabine Alone Versus Cytarabine Plus Anthracycline for Consolidation Therapy in Non-Promyelocytic Acute Myeloid Leukemia

Bilateral Optic Nerve Invasion of Extranodal Marginal Zone B Cell Lymphoma with Leukemic Subtype

Mitoxantrone, Etoposide, and Intermediate-Dose Cytarabine in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia : Single-Center Experience

Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.

Detection of Extracellular Protein Kinase A (ECPKA) Autoantibody in Non-Hodgkin’s Lymphoma: Its Increased Antibody Titer Decreases with a Favorable Treatment Response.

Treatment Outcome of Localized Extranodal NK/T Cell Lymphoma in Nasal and Upper Aerodigestive Tract: A Single Institue Experience in Korea.

Prediction of Survival in Patients with Non-Hodgkin’s Lymphoma: Role of Tumor Necrosis Factor Ligand-Receptor and Extracellular Protein Kinase A.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only